TScan Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
TScan Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q2 2024.
  • TScan Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -35.4 %, a 7.18% increase year-over-year.
  • TScan Therapeutics, Inc. annual Return On Assets for 2023 was -33.9 %, a 12.4% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -35.4 +2.74 +7.18% Apr 1, 2024 Jun 30, 2024
Q1 2024 -34.5 +7.54 +17.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -33.9 +4.8 +12.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -36 +0.59 +1.61% Jul 1, 2023 Sep 30, 2023
Q2 2023 -38.2 -3.81 -11.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42.1 -9.16 -27.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38.7 Oct 1, 2022 Dec 31, 2022
Q3 2022 -36.6 Jul 1, 2022 Sep 30, 2022
Q2 2022 -34.4 Apr 1, 2022 Jun 30, 2022
Q1 2022 -32.9 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.